Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-11 Sale | 2023-09-13 4:29 pm | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 18,000 | $10.5 | $189,050 | 0 (Direct) | View |
| 2023-08-18 Sale | 2023-08-21 8:09 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 8,020 | $10.73 | $86,045 | 88,881 (Direct) | View |
| 2023-08-18 Sale | 2023-08-21 8:07 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 4,976 | $10.73 | $53,386 | 114,676 (Direct) | View |
| 2023-08-18 Sale | 2023-08-21 8:06 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,142 | $10.73 | $76,624 | 83,049 (Direct) | View |
| 2023-08-18 Sale | 2023-08-21 8:05 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y | 13,067 | $10.73 | $140,192 | 184,362 (Direct) | View |
| 2023-08-18 Sale | 2023-08-21 8:05 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 14,876 | $10.73 | $159,602 | 273,112 (Direct) | View |
| 2023-05-18 Sale | 2023-05-19 9:20 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,604 | $10.14 | $26,416 | 112,066 (Direct) | View |
| 2023-05-18 Sale | 2023-05-19 9:19 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y | 4,037 | $10.14 | $40,953 | 259,930 (Direct) | View |
| 2023-05-18 Sale | 2023-05-19 9:18 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 1,786 | $10.14 | $18,118 | 141,527 (Direct) | View |
| 2023-05-18 Sale | 2023-05-19 9:17 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 5,627 | $10.14 | $57,083 | 350,489 (Direct) | View |
| 2023-05-18 Sale | 2023-05-19 9:16 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 2,780 | $10.14 | $28,201 | 130,652 (Direct) | View |
| 2023-02-17 Sale | 2023-02-23 5:44 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 3,412 | $7.66 | $26,136 | 40,791 (Direct) | View |
| 2023-02-17 Sale | 2023-02-23 5:44 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 2,228 | $7.66 | $17,066 | 87,411 (Direct) | View |
| 2023-02-17 Sale | 2023-02-23 5:42 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,727 | $7.66 | $20,889 | 58,768 (Direct) | View |
| 2023-02-17 Sale | 2023-02-23 5:41 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y | 4,954 | $7.66 | $37,948 | 104,243 (Direct) | View |
| 2023-02-17 Sale | 2023-02-23 5:40 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 6,700 | $7.66 | $51,322 | 196,392 (Direct) | View |
| 2022-11-18 Sale | 2022-11-21 4:21 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,139 | $5.44 | $6,196 | 59,065 (Direct) | View |
| 2022-11-18 Sale | 2022-11-21 4:20 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO & Secretary | 722 | $5.44 | $3,928 | 102,253 (Direct) | View |
| 2022-11-18 Sale | 2022-11-21 4:18 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 530 | $5.44 | $2,883 | 87,209 (Direct) | View |
| 2022-11-18 Sale | 2022-11-21 4:17 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 1,785 | $5.44 | $9,710 | 196,148 (Direct) | View |
| 2022-11-18 Sale | 2022-11-21 4:15 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 722 | $5.44 | $3,928 | 39,809 (Direct) | View |
| 2022-09-02 Sale | 2022-09-07 4:50 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 1,320 | $17.01 | $22,458 | 110,858 (Direct) | View |
| 2022-08-17 Sale | 2022-08-19 5:24 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 725 | $14.96 | $10,847 | 37,975 (Direct) | View |
| 2022-08-17 Sale | 2022-08-19 5:17 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 532 | $14.96 | $7,960 | 87,739 (Direct) | View |
| 2022-08-17 Sale | 2022-08-19 5:16 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,145 | $14.96 | $17,130 | 60,204 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-26 Option Award | 2023-09-28 4:55 pm | N/A 2033-09-25 | KalVista Pharmaceuticals Inc. | KALV | Treanor Patrick Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-09-26 Option Award | 2023-09-28 4:54 pm | N/A 2033-09-25 | KalVista Pharmaceuticals Inc. | KALV | Stuart Nancy Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-09-26 Option Award | 2023-09-28 4:54 pm | N/A 2033-09-25 | KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-09-26 Option Award | 2023-09-28 4:53 pm | N/A 2033-09-25 | KalVista Pharmaceuticals Inc. | KALV | Pereira Brian JG Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-09-26 Option Award | 2023-09-28 4:52 pm | N/A 2033-09-25 | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-09-11 Exercise | 2023-09-13 4:29 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 12,000 | $7.88 | 0 (Direct) | View |
| 2023-09-11 Exercise | 2023-09-13 4:29 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 6,000 | $6.71 | 0 (Direct) | View |
| 2023-09-11 Exercise | 2023-09-13 4:29 pm | N/A 2027-09-27 | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 18,000 | $0 | 0 (Direct) | View |
| 2023-08-17 Exercise | 2023-08-21 8:09 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 37,058 | $0 | 88,881 (Direct) | View |
| 2023-08-17 Exercise | 2023-08-21 8:07 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 22,988 | $0 | 114,676 (Direct) | View |
| 2023-08-17 Exercise | 2023-08-21 8:06 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 22,988 | $0 | 83,049 (Direct) | View |
| 2023-08-17 Exercise | 2023-08-21 8:05 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y | 60,390 | $0 | 184,362 (Direct) | View |
| 2023-08-17 Exercise | 2023-08-21 8:05 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 67,164 | $0 | 273,112 (Direct) | View |
| 2023-02-17 Exercise(A) | 2023-05-22 9:40 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,430 | $0 | 26,736 (Direct) | View |
| 2023-02-17 Exercise(A) | 2023-05-22 9:39 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y | 6,944 | $0 | 76,390 (Direct) | View |
| 2023-02-17 Exercise(A) | 2023-05-22 9:37 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 2,430 | $0 | 26,736 (Direct) | View |
| 2023-02-17 Exercise(A) | 2023-05-22 9:36 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 6,944 | $0 | 76,390 (Direct) | View |
| 2023-02-17 Exercise(A) | 2023-05-22 9:35 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 4,027 | $0 | 44,307 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-22 9:33 pm | N/A 2033-05-17 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-01-11 Option Award | 2023-05-19 9:20 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 29,166 | $0 | 112,066 (Direct) | View |
| 2023-05-17 Exercise | 2023-05-19 9:20 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 8,410 | $0 | 112,066 (Direct) | View |
| 2023-01-11 Option Award | 2023-05-19 9:19 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y | 83,334 | $0 | 259,930 (Direct) | View |
| 2023-05-17 Exercise | 2023-05-19 9:19 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y | 18,728 | $0 | 259,930 (Direct) | View |
| 2023-01-11 Option Award | 2023-05-19 9:18 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 29,166 | $0 | 141,527 (Direct) | View |
| 2023-05-17 Exercise | 2023-05-19 9:18 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 8,410 | $0 | 141,527 (Direct) | View |
| 2023-01-11 Option Award | 2023-05-19 9:17 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 83,334 | $0 | 350,489 (Direct) | View |
| 2023-05-17 Exercise | 2023-05-19 9:17 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 25,500 | $0 | 350,489 (Direct) | View |
| 2023-01-11 Option Award | 2023-05-19 9:16 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 48,334 | $0 | 130,652 (Direct) | View |
| 2023-05-17 Exercise | 2023-05-19 9:16 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 12,894 | $0 | 130,652 (Direct) | View |
| 2023-02-17 Exercise | 2023-02-23 5:44 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 12,892 | $0 | 40,791 (Direct) | View |
| 2023-02-17 Exercise | 2023-02-23 5:44 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 8,408 | $0 | 87,411 (Direct) | View |
| 2023-02-17 Exercise | 2023-02-23 5:42 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 8,408 | $0 | 58,768 (Direct) | View |
| 2023-02-17 Exercise | 2023-02-23 5:41 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y | 18,726 | $0 | 104,243 (Direct) | View |
| 2023-02-17 Exercise | 2023-02-23 5:40 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 25,498 | $0 | 196,392 (Direct) | View |
| 2022-11-17 Exercise | 2022-11-21 4:21 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,774 | $0 | 59,065 (Direct) | View |
| 2022-11-17 Exercise | 2022-11-21 4:20 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO & Secretary | 2,419 | $0 | 102,253 (Direct) | View |
| 2022-11-17 Exercise | 2022-11-21 4:18 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 1,774 | $0 | 87,209 (Direct) | View |
| 2022-11-17 Exercise | 2022-11-21 4:17 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 5,805 | $0 | 196,148 (Direct) | View |
| 2022-11-17 Exercise | 2022-11-21 4:15 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 2,419 | $0 | 39,809 (Direct) | View |
| 2022-10-13 Option Award | 2022-10-17 6:37 pm | N/A 2032-10-12 | KalVista Pharmaceuticals Inc. | KALV | Stuart Nancy Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-10-13 Option Award | 2022-10-17 6:36 pm | N/A 2032-10-12 | KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-10-13 Option Award | 2022-10-17 6:35 pm | N/A 2032-10-12 | KalVista Pharmaceuticals Inc. | KALV | Pereira Brian JG Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-10-13 Option Award | 2022-10-17 6:34 pm | N/A 2032-10-12 | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-07-02 Gift | 2022-09-07 4:50 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 6,500 | $0 | 110,858 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-19 5:24 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 2,418 | $0 | 37,975 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-19 5:17 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 1,773 | $0 | 87,739 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-19 5:16 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,773 | $0 | 60,204 (Direct) | View |